Close Menu

In the New York Times, John Tierney writes that having a corporate connection does not necessarily bias a researcher’s work and adds that “the growing obsession with following the money too often leads to nothing but cheap ad hominem attacks.” Tierney says there are two reasons why journalists and ethics boards first look at funding when evaluating someone’s work: “laziness” and “snobbery.” He adds:

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.